Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by ronrydellon Jan 19, 2023 9:27pm
96 Views
Post# 35234690

RE:2-million-dollar fee

RE:2-million-dollar feeWhen you see how the fee is being paid...not in cash....the fee is reasonable in that their is risk involved for the fee to be effectuated at that number as it would relate to cash.

No complaints here...Also the description of the process is set forth in great detail and the deal now is being illuminated and all the vitriol can now be considered in perspective with this increased transparency.

Let's see how Monday's vote goes!
<< Previous
Bullboard Posts
Next >>